Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Baricitinib was effective in treating both early and late onset alopecia areata.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The rash resolved after stopping ponatinib.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.